Browse
Register
Log In
Variables
4291 variables.
Search variables
---------
Activity tracker (CHRIS follow-up) (md_x1_0139)
Administrative data (CHRIS baseline) (md_x0_0022)
Administrative data (CHRIS follow-up) (md_x1_0022)
Affinity-based plasma proteomics (CHRIS baseline) (md_x0_0103)
Affinity-based plasma proteomics (Upcoming, CHRIS baseline) (md_up_0011)
Alcohol (CHRIS baseline) (md_x0_0037)
Alcohol (CHRIS follow-up) (md_x1_0037)
Anthropometry (CHRIS baseline) (md_x0_0012)
Anthropometry (CHRIS follow-up) (md_x1_0012)
Anthropometry form (CHRIS follow-up) (md_x1_0135)
Anxiety (CHRIS baseline) (md_x0_0098)
Anxiety (CHRIS follow-up) (md_x1_0098)
Arthritis (CHRIS follow-up) (md_x1_0130)
Autonomic system (CHRIS baseline) (md_x0_0089)
Autonomic system (CHRIS follow-up) (md_x1_0089)
Baseline information (CHRIS COVID-19) (md_cc_0002)
Biochemical traits (CHRIS COVID-19) (md_cc_0003)
Biochemical traits (CHRIS baseline) (md_x0_0002)
Biochemical traits (CHRIS follow-up) (md_x1_0002)
Birth (CHRIS baseline) (md_x0_0038)
Blood (CHRIS COVID-19) (ms_cc_0002)
Blood (CHRIS NAFLD) (ms_na_0002)
Blood (CHRIS PAREGEN1) (ms_p1_0002)
Blood (CHRIS PAREGEN2) (ms_p2_0002)
Blood (CHRIS baseline) (ms_x0_0002)
Blood (CHRIS follow-up) (ms_x1_0002)
Blood collection form (CHRIS baseline) (md_x0_0007)
Blood collection form (CHRIS follow-up) (md_x1_0007)
Blood drawing pain rating (CHRIS follow-up) (md_x1_0134)
Blood measurements (CHRIS baseline) (md_x0_0009)
Blood measurements (CHRIS follow-up) (md_x1_0009)
Blood pressure (CHRIS baseline) (md_x0_0013)
Blood pressure (CHRIS follow-up) (md_x1_0013)
Blood values (CHRIS baseline) (md_x0_0039)
Blood values (CHRIS follow-up) (md_x1_0039)
CHRIS COVID-19 data (md_cc_0001)
CHRIS COVID-19 samples (ms_cc_0001)
CHRIS NAFLD data (md_na_0001)
CHRIS NAFLD samples (ms_na_0001)
CHRIS PAREGEN1 data (md_p1_0001)
CHRIS PAREGEN1 samples (ms_p1_0001)
CHRIS PAREGEN2 data (md_p2_0001)
CHRIS PAREGEN2 samples (ms_p2_0001)
CHRIS baseline data (md_x0_0001)
CHRIS baseline samples (ms_x0_0001)
CHRIS data (md_x_0001)
CHRIS follow-up data (md_x1_0001)
CHRIS follow-up data (Upcoming CHRIS follow-up) (md_up_0010)
CHRIS follow-up samples (ms_x1_0001)
CHRIS samples (ms_x_0001)
CHRIS sub-study data (md_xs_0001)
CHRIS sub-study samples (ms_xs_0001)
COVID-19 infection (CHRIS follow-up) (md_x1_0123)
COVID-19 vaccination (CHRIS follow-up) (md_x1_0117)
Cancer (CHRIS baseline) (md_x0_0040)
Cancer (CHRIS follow-up) (md_x1_0040)
Cardiac arrhythmias (CHRIS baseline) (md_x0_0041)
Cardiac arrhythmias (CHRIS follow-up) (md_x1_0041)
Cardiovascular diseases (CHRIS baseline) (md_x0_0042)
Cardiovascular diseases (CHRIS baseline) (md_x0_0107)
Cardiovascular traits (CHRIS baseline) (md_x0_0114)
Cardiovascular traits (CHRIS follow-up) (md_x1_0114)
Childhood trauma (CHRIS baseline) (md_x0_0081)
Chronic diseases (CHRIS baseline) (md_x0_0043)
Chronic diseases (CHRIS follow-up) (md_x1_0043)
Chronic pain (CHRIS baseline) (md_x0_0044)
Chronic pain (CHRIS follow-up) (md_x1_0124)
Chronotype (CHRIS baseline) (md_x0_0091)
Circulation (CHRIS baseline) (md_x0_0045)
Circulation (CHRIS follow-up) (md_x1_0045)
Clinical traits (CHRIS baseline) (md_x0_0011)
Clinical traits (CHRIS follow-up) (md_x1_0011)
Cognition (CHRIS baseline) (md_x0_0070)
Complement system (CHRIS baseline) (md_x0_0004)
Complement system, additional batch (Upcoming, CHRIS baseline) (md_up_0009)
Continuous blood pressure measurement (CHRIS baseline) (md_x0_0118)
Corticosteroids (Upcoming, CHRIS baseline) (md_up_0008)
Cumulative Illness Rating Scale (CHRIS baseline) (md_x0_0115)
Data-derived traits (CHRIS baseline) (md_x0_0106)
Data-derived traits (CHRIS follow-up) (md_x1_0106)
Day summary (md_x1_0140)
Demographic data (CHRIS baseline) (md_x0_0024)
Demographic data (CHRIS follow-up) (md_x1_0024)
Depression (CHRIS baseline) (md_x0_0090)
Depression (CHRIS follow-up) (md_x1_0090)
Depression and mania (CHRIS baseline) (md_x0_0085)
Derived traits (CHRIS baseline) (md_x0_0104)
Derived traits (CHRIS follow-up) (md_x1_0104)
Diabetes (CHRIS baseline) (md_x0_0046)
Diabetes (CHRIS follow-up) (md_x1_0046)
Drug intake (CHRIS baseline) (md_x0_0018)
Drug intake (CHRIS follow-up) (md_x1_0018)
Drugs complete dataset (CHRIS follow-up) (md_x1_0019)
Drugs summary (CHRIS baseline) (md_x0_0020)
Drugs summary (CHRIS follow-up) (md_x1_0020)
Dynamic consent survey (CHRIS baseline) (md_x0_0109)
ECG 10s (CHRIS baseline) (md_x0_0015)
ECG 10s (CHRIS follow-up) (md_x1_0015)
ECG 20m (CHRIS baseline) (md_x0_0016)
ECG representations based on 32 generative factors (Upcoming, CHRIS baseline) (md_up_0015)
Early repolarization pattern (CHRIS baseline) (md_x0_0116)
Exposure (CHRIS baseline) (md_x0_0047)
Feces (CHRIS NAFLD) (ms_na_0005)
Flavonoid intake (CHRIS baseline) (md_x0_0078)
Flavonoid intake (CHRIS follow-up) (md_x1_0078)
Food frequency questionnaire (CHRIS baseline) (md_x0_0077)
Food frequency questionnaire (CHRIS follow-up) (md_x1_0077)
General health (CHRIS follow-up) (md_x1_0128)
General information (CHRIS COVID-19) (md_cc_0004)
General information (CHRIS baseline) (md_x0_0021)
General information (CHRIS follow-up) (md_x1_0021)
Genomic variants (CHRIS baseline) (md_x0_0026)
Genomics (CHRIS baseline) (md_x0_0025)
Genotype array (CHRIS baseline) (md_x0_0028)
Gynecology (CHRIS baseline) (md_x0_0048)
Gynecology (CHRIS follow-up) (md_x1_0048)
Handedness (CHRIS follow-up) (md_x1_0136)
Heart failure (CHRIS baseline) (md_x0_0049)
Heart failure (CHRIS follow-up) (md_x1_0049)
Heart rate variability (CHRIS baseline) (md_x0_0113)
Heart rate variability, cardiologist curated (CHRIS baseline) (md_x0_0112)
Hypertension (CHRIS follow-up) (md_x1_0116)
Hypomania (CHRIS baseline) (md_x0_0082)
Illness rating (CHRIS follow-up) (md_x1_0129)
Infectious diseases (CHRIS follow-up) (md_x1_0122)
Informed consent (CHRIS follow-up) (md_x1_0110)
Informed consent (CHRIS baseline) (md_x0_0110)
Insomnia (CHRIS follow-up) (md_x1_0121)
Interpretation (CHRIS follow-up) (md_x1_0133)
Interview (CHRIS baseline) (md_x0_0036)
Interview (CHRIS follow-up) (md_x1_0036)
Iron metabolism (CHRIS baseline) (md_x0_0005)
Iron metabolism (Upcoming, CHRIS baseline) (md_up_0003)
Kidney diseases (CHRIS baseline) (md_x0_0050)
Kidney diseases (CHRIS follow-up) (md_x1_0050)
Lab routine measurements (CHRIS baseline) (md_x0_0008)
Lab routine measurements (CHRIS follow-up) (md_x1_0008)
Longitudinal information (CHRIS COVID-19) (md_cc_0005)
MICROS data (md_mi_0001)
MICROS samples (ms_mi_0001)
Major psychiatric diagnoses (CHRIS baseline) (md_x0_0084)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS COVID 19) (md_up_0014)
Mass-spectrometry plasma proteomics (Upcoming, CHRIS baseline, CHRIS NAFLD) (md_up_0007)
Mass-spectrometry plasma proteomics: peptides (CHRIS NAFLD) (md_na_0101)
Mass-spectrometry plasma proteomics: peptides (CHRIS baseline) (md_x0_0101)
Mass-spectrometry plasma proteomics: proteins (CHRIS NAFLD) (md_na_0102)
Mass-spectrometry plasma proteomics: proteins (CHRIS baseline) (md_x0_0102)
Metabolomics (CHRIS NAFLD) (md_na_0063)
Metabolomics (CHRIS baseline) (md_x0_0063)
Metagenomes from saliva and feces (Upcoming, CHRIS NAFLD) (md_up_0016)
Migraine (CHRIS baseline) (md_x0_0051)
Mitochondrial DNA (Upcoming, CHRIS baseline) (md_up_0019)
Mitochondrial DNA copy number (CHRIS baseline) (md_x0_0006)
Movement disorder examination (CHRIS baseline) (md_x0_0111)
Myocardial infarction (CHRIS baseline) (md_x0_0052)
Myocardial infarction (CHRIS follow-up) (md_x1_0052)
NAFLD sub-study data (Upcoming CHRIS NAFLD) (md_up_0006)
NOT IN USE (md_x_0003)
NOT IN USE md_x0_0033 (md_x0_0033)
NOT IN USE md_x0_0034 (md_x0_0034)
NOT IN USE md_x0_0122 (md_x0_0122)
NOT IN USE md_x0_0123 (md_x0_0123)
NOT IN USE md_x0_0124 (md_x0_0124)
NOT IN USE md_x0_0125 (md_x0_0125)
NOT IN USE ms_x0_0005 (ms_x0_0005)
NOT IN USE ms_x0_0006 (ms_x0_0006)
NOT IN USE ms_x0_0007 (ms_x0_0007)
NOT IN USE ms_x0_0008 (ms_x0_0008)
NOT IN USE ms_x0_0009 (ms_x0_0009)
NOT IN USE ms_x0_0010 (ms_x0_0010)
NOT IN USE ms_x0_0011 (ms_x0_0011)
NOT IN USE test (test)
NOT IN USE upcoming_0001 (upcoming_0001)
NOT IN USE upcoming_0002 (upcoming_0002)
NOT IN USE upcoming_0003 (upcoming_0003)
NOT IN USE upcoming_0004 (upcoming_0004)
Neurological phenotypes (CHRIS baseline) (md_x0_0108)
Neurological phenotypes (CHRIS follow-up) (md_x1_0108)
Neurological tests (CHRIS baseline) (md_x0_0068)
Neurological tests (CHRIS follow-up) (md_x1_0068)
Neurology (CHRIS baseline) (md_x0_0053)
Neurology (CHRIS follow-up) (md_x1_0053)
Neuropsychiatry questionnaire (CHRIS baseline) (md_x0_0080)
Neutralizing Antibody (CHRIS COVID-19) (md_cc_0006)
Notes (CHRIS follow-up) (md_x1_0138)
Nutrient intake (CHRIS baseline) (md_x0_0079)
Nutrient intake (CHRIS follow-up) (md_x1_0079)
Nutrition (CHRIS baseline) (md_x0_0054)
Occupation (CHRIS baseline) (md_x0_0055)
Occupation (CHRIS follow-up) (md_x1_0055)
Olfaction (CHRIS follow-up) (md_x1_0118)
Olfactory test (CHRIS baseline) (md_x0_0071)
Olfactory test (CHRIS follow-up) (md_x1_0071)
Optimism and pessimism (CHRIS baseline) (md_x0_0083)
Oral health (CHRIS baseline) (md_x0_0099)
Other diseases (CHRIS baseline) (md_x0_0056)
PAREGEN sub-study data (Upcoming, CHRIS PAREGEN) (md_up_0017)
PAREGEN2 sub-study data (Upcoming, CHRIS PAREGEN2) (md_up_0018)
Pain Sensitivity (CHRIS follow-up) (md_x1_0092)
Pain pressure threshold (CHRIS baseline) (md_x0_0069)
Pain sensitivity (CHRIS baseline) (md_x0_0092)
Pain sensitivity assessement (CHRIS follow-up) (md_x1_0119)
Pain staging (CHRIS follow-up) (md_x1_0125)
Parkinson screening (CHRIS baseline) (md_x0_0057)
Participant satisfaction survey (CHRIS follow-up) (md_x1_0132)
Participation information (CHRIS baseline) (md_x0_0023)
Participation information (CHRIS follow-up) (md_x1_0023)
Pedigree (CHRIS baseline) (md_x0_0074)
Person (CHRIS baseline) (md_x0_0058)
Person (CHRIS follow-up) (md_x1_0058)
Physical activity (CHRIS baseline) (md_x0_0093)
Physical activity (CHRIS follow-up) (md_x1_0093)
Proteomics (CHRIS NAFLD) (md_na_0100)
Proteomics (CHRIS baseline) (md_x0_0100)
Public imputation panels (CHRIS baseline) (md_x0_0027)
REM sleep (CHRIS baseline) (md_x0_0095)
REM sleep (CHRIS follow-up) (md_x1_0095)
Raw recordings ECG 10s (CHRIS baseline) (md_x0_0119)
Raw recordings ECG 20m (CHRIS baseline) (md_x0_0120)
Raw recordings spiralography (CHRIS baseline) (md_x0_0121)
Renin-angiotensin-aldosteron system (Upcoming, CHRIS baseline) (md_up_0005)
Resting ECG (CHRIS baseline) (md_x0_0014)
Resting ECG (CHRIS follow-up) (md_x1_0014)
Restless Legs Syndrome (CHRIS baseline) (md_x0_0096)
SARS-CoV-2 antibody (CHRIS follow-up) (md_x1_0115)
Saliva (CHRIS NAFLD) (ms_na_0004)
Saliva (CHRIS baseline) (ms_x0_0004)
Saliva microbiome (Upcoming, CHRIS baseline) (md_up_0013)
Sample-derived traits (CHRIS baseline) (md_x0_0105)
Sample-derived traits (CHRIS follow-up) (md_x1_0105)
Self-Assessement (CHRIS baseline) (md_x0_0076)
Self-Assessement (CHRIS follow-up) (md_x1_0076)
Self-Assessement at home (CHRIS follow-up) (md_x1_0127)
Self-reported ancestry (CHRIS baseline) (md_x0_0075)
Sleep behavior (CHRIS follow-up) (md_x1_0120)
Sleep quality (CHRIS baseline) (md_x0_0094)
Smoking (CHRIS baseline) (md_x0_0059)
Smoking (CHRIS follow-up) (md_x1_0059)
Socio-economic panel (CHRIS follow-up) (md_x1_0126)
Socio-economic panel, at home (CHRIS follow-up) (md_x1_0131)
Spiralography (CHRIS baseline) (md_x0_0072)
Stress perception (CHRIS baseline) (md_x0_0086)
Stroke (CHRIS baseline) (md_x0_0060)
Stroke (CHRIS follow-up) (md_x1_0060)
Summary (md_x1_0141)
Surgeries (CHRIS follow-up) (md_x1_0137)
TOPMed-imputed genotypes (CHRIS baseline) - NOT IN USE (md_x0_0030)
Targeted serum metabolomics (CHRIS NAFLD) (md_na_0065)
Targeted serum metabolomics (CHRIS baseline) (md_x0_0065)
Targeted serum metabolomics, expanded set (CHRIS baseline) (md_x0_0064)
Targeted serum metabolomics, expanded set (Upcoming, CHRIS baseline) (md_up_0004)
Temperament (CHRIS baseline) (md_x0_0087)
Thyroid diseases (CHRIS baseline) (md_x0_0061)
Thyroid diseases (CHRIS follow-up) (md_x1_0061)
Touchscreen (CHRIS baseline) (md_x0_0088)
Touchscreen (CHRIS follow-up) (md_x1_0088)
Untargeted serum metabolomics (Upcoming, CHRIS baseline) (md_up_0012)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS NAFLD) (md_na_0066)
Untargeted serum metabolomics, small polar metabolites, negative polarity (CHRIS baseline) (md_x0_0066)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS NAFLD) (md_na_0067)
Untargeted serum metabolomics, small polar metabolites, positive polarity (CHRIS baseline) (md_x0_0067)
Upcoming datasets (md_up_0001)
Urine (CHRIS NAFLD) (ms_na_0003)
Urine (CHRIS baseline) (ms_x0_0003)
Urine (CHRIS follow-up) (ms_x1_0003)
Urine measurements (CHRIS baseline) (md_x0_0010)
Urine measurements (CHRIS follow-up) (md_x1_0010)
Vaccination (CHRIS baseline) (md_x0_0062)
Vaccination status (CHRIS COVID-19) (md_cc_0007)
Whole-exome sequencing (CHRIS baseline) (md_x0_0029)
Whole-exome sequencing imputation (CHRIS baseline) (md_x0_0031)
Whole-exome sequencing raw data (CHRIS baseline) (md_x0_0032)
Without expected release date (md_up_0002)
Module
---------
Label
Character
Integer
Categorical
Float
Date
Time
Datetime
Boolean
Type
Search
Clear
Module
Label
Name
Description
Type
Nutrient intake (CHRIS baseline)
x0nu126
Total daily cis n-6 C20:2 /100g food
Total daily cis n-6 C20:2 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu128
Total daily cis n-6 C20:3 /100g food
Total daily cis n-6 C20:3 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu130
Total daily cis n-6 C20:4 /100g food
Total daily cis n-6 C20:4 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu137
Total daily cis n-6 C22:2 /100g food
Total daily cis n-6 C22:2 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu138
Total daily cis n-6 C22:3 /100g food
Total daily cis n-6 C22:3 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu140
Total daily cis n-6 C22:4 /100g food
Total daily cis n-6 C22:4 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu022a
Total daily cis-Mono FA /100g FA
Total daily cis-Mono FA /100g FA (g)
Float
Nutrient intake (CHRIS baseline)
x0nu022b
Total daily cis-Mono FA /100g Food
Total daily cis-Mono FA /100g Food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu024b
Total daily cis-Poly FA /100g Food
Total daily cis-Poly FA /100g Food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu024a
Total daily cis-Polyu FA /100g FA
Total daily cis-Polyu FA /100g FA (g)
Float
Nutrient intake (CHRIS baseline)
x0nu101
Total daily cis/trans C18:1n-7 /100g food
Total daily cis/trans C18:1n-7 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu100
Total daily cis/trans C18:1n-9 /100g food
Total daily cis/trans C18:1n-9 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu106
Total daily cis/trans C22:1n-11 /100g food
Total daily cis/trans C22:1n-11 /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu107
Total daily cis/trans C22:1n-9 /100g food
Total daily cis/trans C22:1n-9 /100g food (g)
Float
Flavonoid intake (CHRIS baseline)
x0fl004
Total daily flavan-3-ols
Total daily flavan-3-ols
Float
Flavonoid intake (CHRIS baseline)
x0fl006
Total daily flavones
Total daily flavones
Float
Flavonoid intake (CHRIS baseline)
x0fl005
Total daily flavonols
Total daily flavonols
Float
Nutrient intake (CHRIS baseline)
x0nu021a
Total daily n-3 poly /100g FA
Total daily n-3 poly /100g FA (g)
Float
Nutrient intake (CHRIS baseline)
x0nu021b
Total daily n-3 poly /100g food
Total daily n-3 poly /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu020a
Total daily n-6 poly /100g FA
Total daily n-6 poly /100g FA (g)
Float
Nutrient intake (CHRIS baseline)
x0nu020b
Total daily n-6 poly /100g food
Total daily n-6 poly /100g food (g)
Float
Flavonoid intake (CHRIS baseline)
x0fl010
Total daily naringenin
Total daily naringenin
Float
Nutrient intake (CHRIS baseline)
x0nu110
Total daily trans monounsaturated /100g food
Total daily trans monounsaturated /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu146
Total daily trans poly /100g food
Total daily trans poly /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu116
Total daily unknown C16 poly /100g food
Total daily unknown C16 poly /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu124
Total daily unknown C18 poly /100g food
Total daily unknown C18 poly /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu133
Total daily unknown C20 poly /100g food
Total daily unknown C20 poly /100g food (g)
Float
Nutrient intake (CHRIS baseline)
x0nu145
Total daily unknown C22 poly /100g food
Total daily unknown C22 poly /100g food (g)
Float
Physical activity (CHRIS baseline)
x0ip08
Total physical activity MET-minutes/week
Total physical activity MET-minutes/week
Float
Blood measurements (CHRIS baseline)
x0lp31
Transferrin saturation (TSat)
Transferrin saturation (TSat)
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt034
Trp
Tryptophan
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt035
Tyr
Tyrosine
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec09
Ultra Low Frequency (ULF) power
Ultra Low Frequency (ULF) power
Float
Blood measurements (CHRIS baseline)
x0lp08
Uric acid
Uric acid
Float
Urine measurements (CHRIS baseline)
x0lp63
Urine albumin/creatinine ratio (UACR)
Urine albumin/creatinine ratio (UACR)
Float
Urine measurements (CHRIS baseline)
x0lp53
Urine pH
Urine pH
Float
Gynecology (CHRIS baseline)
x0wo04b
Use of contraceptive pills
How many months or years have you taken contraceptives?
Float
Heart rate variability (CHRIS baseline)
x0ec250
VLF peak (AR)
Very Low Frequency (VLF) band peak frequency, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in Hz
Float
Heart rate variability (CHRIS baseline)
x0ec233
VLF peak (Welch)
Very Low Frequency (VLF) band peak frequency, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in Hz
Float
Heart rate variability (CHRIS baseline)
x0ec261
VLF power (%) (AR)
Relative power of VLF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec244
VLF power (%) (Welch)
Relative power of VLF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec253
VLF power (AR)
Absolute power of VLF band, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec236
VLF power (Welch)
Absolute power of VLF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt036
Val
Valine
Float
Heart rate variability, cardiologist curated (CHRIS baseline)
x0ec10
Very Low Frequency (VLF) power
Very Low Frequency (VLF) power
Float
Physical activity (CHRIS baseline)
x0ip07
Walking MET-minutes/week
Walking MET-minutes/week
Float
Anthropometry (CHRIS baseline)
x0an02
Weight
Weight
Float
Blood measurements (CHRIS baseline)
x0lp39
White Blood Cell Count (WBC)
White Blood Cell Count (WBC)
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt003
alpha-AAA
alpha-Aminoadipic acid
Float
Heart rate variability (CHRIS baseline)
x0ec203
effective length
Effective length of the ECG which is used for HRV analysis, expressed in seconds
Float
Heart rate variability (CHRIS baseline)
x0ec204
effective length (%)
Effective data length, expressed as percentage of the total length
Float
Blood measurements (CHRIS baseline)
x0lp86a
estimated Glomerular filtration rate (eGFR) CKDEPI crea
estimated Glomerular filtration rate (eGFR) CKDEPI crea
Float
Blood measurements (CHRIS baseline)
x0lp86b
estimated Glomerular filtration rate (eGFR) MDRD4
estimated Glomerular filtration rate (eGFR) MDRD4
Float
Heart rate variability (CHRIS baseline)
x0ec259
logHF power (AR)
Natural logarithm transformed values of HF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec242
logHF power (Welch)
Natural logarithm transformed values of HF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec258
logLF power (AR)
Natural logarithm transformed values of LF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec241
logLF power (Welch)
Natural logarithm transformed values of LF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec257
logVLF power (AR)
Natural logarithm transformed values of VLF band, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec240
logVLF power (Welch)
Natural logarithm transformed values of VLF band, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Heart rate variability (CHRIS baseline)
x0ec260
logtot power (AR)
Natural logarithm transformed values of total spectrum power, with PSD estimated using parametric autoregressive (AR) modeling method
Float
Heart rate variability (CHRIS baseline)
x0ec243
logtot power (Welch)
Natural logarithm transformed values of total spectrum power, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt072
lysoPC a C14:0
lysoPhosphatidylcholine acyl C14:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt073
lysoPC a C16:0
lysoPhosphatidylcholine acyl C16:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt074
lysoPC a C16:1
lysoPhosphatidylcholine acyl C16:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt075
lysoPC a C17:0
lysoPhosphatidylcholine acyl C17:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt076
lysoPC a C18:0
lysoPhosphatidylcholine acyl C18:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt077
lysoPC a C18:1
lysoPhosphatidylcholine acyl C18:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt078
lysoPC a C18:2
lysoPhosphatidylcholine acyl C18:2
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt079
lysoPC a C20:3
lysoPhosphatidylcholine acyl C20:3
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt080
lysoPC a C20:4
lysoPhosphatidylcholine acyl C20:4
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt081
lysoPC a C24:0
lysoPhosphatidylcholine acyl C24:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt082
lysoPC a C26:0
lysoPhosphatidylcholine acyl C26:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt083
lysoPC a C26:1
lysoPhosphatidylcholine acyl C26:1
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt084
lysoPC a C28:0
lysoPhosphatidylcholine acyl C28:0
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt085
lysoPC a C28:1
lysoPhosphatidylcholine acyl C28:1
Float
Heart rate variability (CHRIS baseline)
x0ec225
max HR
Maximum HR computed using N=5 beat moving average
Float
Heart rate variability (CHRIS baseline)
x0ec222
mean HR
Mean heart rate, expressed in beats per minute
Float
Heart rate variability (CHRIS baseline)
x0ec215
mean RR
Mean value of RR intervals, expressed in milliseconds
Float
Heart rate variability (CHRIS baseline)
x0ec224
min HR
Minimum HR computed using N=5 beat moving average
Float
Mitochondrial DNA copy number (CHRIS baseline)
x0mt01
mtDNA copy number
mtDNA copy number
Float
Mitochondrial DNA copy number (CHRIS baseline)
x0mt01a
mtDNA copy number (2nd measurement)
mtDNA copy number (2nd measurement)
Float
Heart rate variability (CHRIS baseline)
x0ec210
number of corrected beats (%)
Number of corrected beats, expressed as percentage of the total number of beats
Float
Heart rate variability (CHRIS baseline)
x0ec219
pNN50
pNN50: NN50 divided by the total number of RR intervals
Float
Heart rate variability (CHRIS baseline)
x0ec223
std HR
Standard deviation of heart rate
Float
Targeted serum metabolomics (CHRIS baseline)
x0pt031
t4-OH-Pro
trans-4-Hydroxyproline
Float
Heart rate variability (CHRIS baseline)
x0ec207b
t_RR end
Time point of the last beat in the RR series, expressed in seconds
Float
Heart rate variability (CHRIS baseline)
x0ec207a
t_RR start
Time point of the first beat in the RR series, expressed in seconds
Float
Heart rate variability (CHRIS baseline)
x0ec202
total length of the ECG
Total length of the ECG recording, expressed in seconds
Float
Heart rate variability (CHRIS baseline)
x0ec256
total power (AR)
Absolute power of the total spectrum, with PSD estimated using parametric autoregressive (AR) modeling method, expressed in ms^2
Float
Heart rate variability (CHRIS baseline)
x0ec239
total power (Welch)
Absolute power of the total spectrum, with PSD estimated using Fast Fourier transformation (FFT) based Welch's periodogram method, expressed in ms^2
Float
Depression and mania (CHRIS baseline)
x0np13
A6 - frequency
How many episodes of depression did you have in your lifetime?
Integer
Demographic data (CHRIS baseline)
x0_ager
Age at examination, rounded
Age at participation (rounded to the nearest full year)
Integer
Depression and mania (CHRIS baseline)
x0np14
Age at onset - depression
How old were you when your first depressive episode started?
Integer
Smoking (CHRIS baseline)
x0sm56
Age at smoking onset
Age at smoking onset
Integer
General information (CHRIS COVID-19)
cc_age
Age on February 1st, 2020
Age on February 1st, 2020, truncated to whole years
Integer
Major psychiatric diagnoses (CHRIS baseline)
x0mp08b
Agoraphobia (age at onset)
Agoraphobia: Age at onset
Integer
Blood measurements (CHRIS baseline)
x0lp11
Alanine aminotransferase (ALT)
Alanine aminotransferase (ALT), glutamate pyruvate transaminase (GPT)
Integer
Alcohol (CHRIS baseline)
x0al08
Alcohol Addiction scale (CAGE)
Alcohol Addiction scale (CAGE)
Integer
Major psychiatric diagnoses (CHRIS baseline)
x0mp02b
Alcohol abuse (age at onset)
Alcohol abuse: Age at onset
Integer
Alcohol (CHRIS baseline)
x0al03a
Alcohol consumption (weekend): Alcohol-free beer
During the last 12 months, how many of the following beverages have you usually drunk on a weekend (Friday, Saturday, Sunday)? Alcohol-free beer (No. of glasses a 0.2 I)
Integer
Previous
1
34
35
36
37
38
43
Next